Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line

Cancer Res. 1990 Oct 1;50(19):6316-22.

Abstract

The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit N-myc gene expression in the neuroepithelioma cell line CHP100. These cells contain single copy N-myc alleles but overexpress c-myc. N-myc antisense oligomer treatment was found to be growth inhibitory without affecting levels of c-myc protein. N-myc antisense oligomer-treated cells also lost the characteristic cellular heterogeneity displayed by CHP100 in vitro.

MeSH terms

  • Cell Division / drug effects
  • DNA, Neoplasm / biosynthesis
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Humans
  • Neuroectodermal Tumors, Primitive, Peripheral / genetics*
  • Neuroectodermal Tumors, Primitive, Peripheral / pathology
  • Oligonucleotides / pharmacology*
  • Oligonucleotides, Antisense
  • Oncogenes*
  • Protein Biosynthesis*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger / analysis
  • RNA, Neoplasm / analysis
  • Time Factors

Substances

  • DNA, Neoplasm
  • Oligonucleotides
  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • RNA, Neoplasm